EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

Breaktroughs in Eosinophilic Esophagitis

Monday 03 Jun, 12:45 PM - 14:15 PM Valencia, Spain
Granada Oral Abstract Sessions
12:45
Transcriptomic profiling of the acute response to local esophageal food injections in adult patients with eosinophilic esophagitis
12:57
Expression of GPR15 and CD38 on peripheral blood pathogenic effector Th2 cells can identify active eosinophilic esophagitis
13:09
Ultraprocessed foods induce in situ differentiation of eosinophils in the esophageal mucosa: new insights for the pathogenesis of pediatric eosinophilic esophagitis
13:21
Dupilumab is Efficacious in Children (Aged 1 to <12 Years) With Eosinophilic Esophagitis Regardless of Prior History of Comorbidities
13:33
Dupilumab efficacy in patients with an inadequate response, intolerance, or contraindication to swallowed topical corticosteroids: a subgroup analysis of data from the phase 3 LIBERTY EoE TREET study
13:45
Plasma Biomarkers Differentiate Active and Inactive Eosinophilic Esophagitis
13:57
Clinical and histopathologic response following empiric food elimination diet in children with eosinophilic gastritis

Speakers